| ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. F Peyvandi, S Lavoretano, R Palla, HB Feys, K Vanhoorelbeke, ... haematologica 93 (2), 232-239, 2008 | 304 | 2008 |
| Complement activation in thrombotic thrombocytopenic purpura M Reti, P Farkas, D Csuka, K Razso, A Schlammadinger, ML Udvardy, ... Journal of Thrombosis and Haemostasis 10 (5), 791-798, 2012 | 171 | 2012 |
| Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection G Sinkovits, B Mező, M Réti, V Müller, Z Iványi, J Gál, L Gopcsa, ... Frontiers in immunology 12, 663187, 2021 | 103 | 2021 |
| Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL AF Rendeiro, T Krausgruber, N Fortelny, F Zhao, T Penz, M Farlik, ... Nature Communications 11 (1), 577, 2020 | 81 | 2020 |
| Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura E Roose, AS Schelpe, E Tellier, G Sinkovits, BS Joly, C Dekimpe, ... Blood, The Journal of the American Society of Hematology 136 (3), 353-361, 2020 | 76 | 2020 |
| Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans I Vályi-Nagy, Z Matula, M Gönczi, S Tasnády, G Bekő, M Réti, É Ajzner, ... Geroscience 43 (5), 2321-2331, 2021 | 72 | 2021 |
| Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib A Gángó, D Alpár, B Galik, D Marosvári, R Kiss, V Fésüs, D Aczél, ... International Journal of Cancer 146 (1), 85-93, 2020 | 62 | 2020 |
| Early experience with CliniMACS prodigy CCS (IFN-gamma) system in selection of virus-specific T cells from third-party donors for pediatric patients with severe viral … K Kállay, C Kassa, M Réti, É Karászi, J Sinkó, V Goda, A Stréhn, ... Journal of Immunotherapy 41 (3), 158-163, 2018 | 52 | 2018 |
| Alloimmune and autoimmune background in recurrent pregnancy loss–successful immunotherapy by intravenous immunoglobulin B Kotlan, A Padanyi, J Batorfi, V Fulop, I Szigetvari, K Rajczy, M Penzes, ... American Journal of Reproductive Immunology 55 (5), 331-340, 2006 | 43 | 2006 |
| Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome N Szarvas, Á Szilágyi, D Csuka, B Takács, K Rusai, T Müller, K Arbeiter, ... Molecular immunology 71, 10-22, 2016 | 38 | 2016 |
| The potential role of HLA-DRB1* 11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy K Balassa, H Andrikovics, P Remenyi, A Batai, A Bors, KP Kiss, A Szilvasi, ... Bone Marrow Transplantation 50 (10), 1321-1325, 2015 | 35 | 2015 |
| Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies P Farkas, D Csuka, B Mikes, G Sinkovits, M Réti, E Németh, K Rácz, ... Immunobiology 222 (2), 119-127, 2017 | 34 | 2017 |
| Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSF P Reményi, L Gopcsa, I Marton, M Réti, G Mikala, M Pető, A Barta, A Bátai, ... Advances in therapy 31, 451-460, 2014 | 33 | 2014 |
| Decreased neutrophil extracellular trap degradation in Shiga toxin-associated haemolytic uraemic syndrome J Leffler, Z Prohászka, B Mikes, G Sinkovits, K Ciacma, P Farkas, M Réti, ... Journal of innate immunity 9 (1), 12-21, 2017 | 31 | 2017 |
| HLA-G gene polymorphism in the normal population and in recurrent spontaneous abortion in Hungary M Penzes, K Rajczy, E Gyodi, M Reti, E Feher, G Petranyi Transplantation proceedings 31 (4), 1832-1833, 1999 | 31 | 1999 |
| Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it’s not too late GW Basak, G Mikala, Z Koristek, O Jaksic, S Basic-Kinda, A Cegledi, ... Leukemia & lymphoma 52 (9), 1711-1719, 2011 | 28 | 2011 |
| Concentration and subclass distribution of anti-ADAMTS13 IgG autoantibodies in different stages of acquired idiopathic thrombotic thrombocytopenic purpura G Sinkovits, Á Szilágyi, P Farkas, D Inotai, A Szilvási, A Tordai, K Rázsó, ... Frontiers in Immunology 9, 1646, 2018 | 27 | 2018 |
| Immunologic consequences of blood transfusion and their clinical manifestations GG Petrányi, M Réti, V Harsányi, J Szabo International archives of allergy and immunology 114 (4), 303-315, 1997 | 26 | 1997 |
| The role of human leukocyte antigen DRB1-DQB1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura G Sinkovits, Á Szilágyi, P Farkas, D Inotai, A Szilvási, A Tordai, K Rázsó, ... Human Immunology 78 (2), 80-87, 2017 | 25 | 2017 |
| Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura B Mikes, G Sinkovits, P Farkas, D Csuka, Á Schlammadinger, K Rázsó, ... Thrombosis research 133 (4), 616-621, 2014 | 25 | 2014 |
